A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3A Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension

Trial Profile

A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3A Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension

Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2018

At a glance

  • Drugs Travoprost (Primary)
  • Indications Glaucoma; Ocular hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Ocular Therapeutix
  • Most Recent Events

    • 08 Mar 2018 According to an Ocular Therapeutix media release, topline efficacy data from this trial is expected in the fourth quarter of 2018.
    • 07 Sep 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 08 Aug 2017 According to an Ocular Therapeutix media release, topline efficacy data from this trial is expected in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top